e-Article
Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trial
Document Type
Article
Author
Konopleva, M.Y.; Röllig, C.; Cavenagh, J.; Deeren, D.; Girshova, L.; Krauter, J.; Martinelli, G.; Montesinos, P.; Rodriguez-Veiga, R.; Schäfer, J.A.; Ottmann, O.; Petrini, M.; Pigneux, A.; Rambaldi, A.; Recher, C.; Taussig, D.; Vey, N.; Yoon, S.-S.; Ott, M.; Muehlbauer, S.; Catalani, O.; Genevray, M.; Mundt, K.; Jamois, C.; Beckermann, B.M.; Fenaux, P.; Wei, A.H.
Source
In: Blood Advances . (Blood Advances, 26 July 2022, 6(14):4147-4156)
Subject
Language
English
ISSN
24739537
24739529
24739529